Author(s)Amy Paturel, M.S., M.P.H. A rare virus coupled with an ailing immune system can lead to Kaposi’s sarcoma. Restoring immune function can help fight it. Alex C.* was a teenager in 2007 when ...

Behind one fifth of cancer cases around the world lurks a pathogen. The connective-tissue cancer Kaposi sarcoma even gave its name to the herpesvirus that causes it: Kaposi sarcoma-associated ...

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) The following represents disclosure information provided by authors ...

Patients with HIV-negative Kaposi sarcoma (KS) can be successfully treated with immunotherapy even if they also have psoriasis or other skin conditions, according to a new case report. The paper ...

Kaposi sarcoma, a type of vascular cancer once only seen in elderly people of Jewish or Mediterranean descent, is one of the two most common opportunistic diseases associated with AIDS. Its spread, ...

While speaking at the handover ceremony of the National Aids Council (NAC) support to KIDZCAN for child cancer initiatives, ...

The US Food and Drug Administration (FDA) has granted accelerated approval to pomalidomide (Pomalyst, Bristol-Myers Squibb) for the treatment of AIDS-related Kaposi sarcoma that is resistant to highly ...

G-doctor with older man In this case series, all 9 affected patients were Black or Hispanic. Post-transplant Kaposi sarcoma, while rare, appears to occur more often in minorities, according to a ...

The "Kaposi Sarcoma - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Kaposi Sarcoma was estimated at US$162.3 Million in 2023 and ...

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) The following represents disclosure information provided by authors ...